Skip to main content

Advertisement

Table 3 Pregnant women group baseline characteristics of included studies

From: Toxoplasmosis seroprevalence in Iranian women and risk factors of the disease: a systematic review and meta-analysis

Province Total individuals IgG-positive cases (%) IgM-positive cases (%) IgG- and IgM-positive cases (%) Total prevalence (%) Authors
Kermanshah 495 162(32.72)    162(32.72) Athari et al., 1994
Mazandaran 612 435(71.07)    435(71.07) Saffar et al., 1999
Isfahan 317 98(30.91) 4(1.26)   102(32.17) Talari et al., 2001
Isfahan 340 207(60.88)    207(60.88) Arbabi et al., 2002
Tehran 4120 2804(68.05)    2804(68.05) Gharavi et al., 2002
Tehran 140 48(34.28) 10(7.14)   58(41.42) Noorbakhsh et al., 2002
Isfahan 270 72(26.66) 15(5.55)   87(32.22) Talari et al., 2003
Hormozgan 418 143(34.21) 33(7.89) 10(2.39) 186(44.49) SotoudehJahromi et al., 2003
Qom 600 257(42.83)    257(42.83) Mardani et al., 2003
Sistan and Baluchestan 200 54(27)    54(27) Sharifi Mood et al., 2004
Chaharmahal and Bakhtiari 384 106(27.60)    106(27.60) Manuchehri et al., 2007
Khuzestan 79 28(35.44)    28(35.44) Sohrabi et al., 2007
Ilam 553 247(44.66)    247(44.66) Abdi et al., 2008
Hamedan 576 193(33.50)    193(33.50) Fallah et al., 2008
Qazvin 255 160(62.74)    160(62.74) Eskandarian et al., 2009
Kurdistan 201 54(26.86) 24(11.94) 33(16.41) 111(55.22) Parvizpour et al., 2010
Lorestan 390 121(31.02) 29(7.43)   150(38.46) Cheraghi Pour et al., 2010
Lorestan 331 130(39.27) 35(10.57)   165(49.84) Cheraghi Pour et al., 2010
Isfahan 127 67(52.75)    67(52.75) Ghasemi et al., 2011
Zanjan 500 186(37.2) 7(1.4)   193(38.60) Hajsoleimani et al., 2012
Hormozgan 608 252(41.44)    252(41.44) JamshidiMakiani et al., 2012
East Azerbaijan 300 79(26.33) 1(0.33)   80(26.66) DalimiAsl et al., 2012
Mazandaran 1057 739(69.91) 57(5.39)   796(75.30) SiyadatPanah et al., 2013
Qom 200 76(38) 11(5.5)   87(43.50) Akhlaghi et al., 2013
Razavi Khorasan 419 144(34.36)   27(18.75)a 171(40.81) Babaie et al., 2013
Hamedan 350 105(30)   3(2.85)b 108(30.85) Maghsood et al., 2013
Sistan and Baluchestan 221 68(30.76) 3(1.35) 3(1.35) 74(33.48) Ebrahimzadeh et al., 2013
Lorestan 496 154(31.04)   35(22.72)c 189(38.10) RostamiNejad et al., 2013
Qom 400 145(36.25) 21(5.25)   166(41.50) Maleki et al., 2013
Markazi 308 117(37.98)   3(1.74)d 120(38.96) Vakil et al., 2014
Mazandaran 289 170(58.82) 7(2.42) 4(1.38) 181(62.62) Hoseini et al., 2014
Sistan and Baluchestan 185 19(10.27) 1(0.54) 1(0.54) 21(11.35) Mousavi et al., 2014
Mazandaran 175 106(60.57)    106(60.57) Kalantari et al., 2014
Golestan 555 221(39.81) 19(3.42) 8(1.44) 248(44.68) Sharbatkhori et al., 2014
Khuzestan 501 137(27.34) 7(1.39) 3(0.59) 147(29.34) Yadyad et al., 2014
Tehran 785 244(31.08)    244(31.08) Ghasemloo et al., 2014
East Azerbaijan 195 115(58.97)    115(58.97) Haji SeidJavadi et al., 2014
Mazandaran 50 26(52)    26(52) ElahianFirouz et al., 2014
Yazd 181 58(32.04)    58(32.04) Anvari et al., 2014
Alborz 400 116(29) 4(1)   120(30) Akhlaghi et al., 2014
Isfahan 798 341(42.73) 5(0.62)   346(43.35) Rasti et al., 2015
Qazvin 200 58(29) 4(2)   62(31) Tabatabaieet al., 2015
East Azerbaijan 391 267(68.28)    267(68.28) Rajaii et al., 2015
Hamedan 2523 681(26.99) 51(2.02)   732(29.01) Hamidi et al., 2015
Khuzestan 110 47(42.72) 3(2.72)   50(45.45) Saki et al., 2016
  1. aTotal individuals for IgM seropositivity is 144
  2. bTotal individuals for IgM seropositivity is 105
  3. cTotal individuals for IgM seropositivity is 154
  4. dTotal individuals for IgM seropositivity is 172